Navigation Links
DIA Conference to Provide FDA, EMEA, Health Canada, Emerging Regions, NGO, and Industry Perspectives on Global Vaccine Development
Date:9/29/2009

The Drug Information Association (DIA) will present FDA, EMEA, Health Canada, emerging region, NGO, and industry perspectives on Global Vaccine Development at the Global Vaccine Development for World Health Symposium from November 3-4 in Bethesda, MD.

Horsham, PA (Vocus) -- The Drug Information Association (DIA) will present FDA, EMEA, Health Canada, emerging region, NGO, and industry perspectives on Global Vaccine Development at the Global Vaccine Development for World Health Symposium from November 3-4 in Bethesda, MD. This two-day symposium will address the regulatory pathways for the development of global vaccines to treat infectious diseases such as tuberculosis, malaria and H1N1.

Representatives and regulatory experts from the US Food and Drug Administration (FDA), World Health Organization (WHO), Bill & Melinda Gates Foundation, International Vaccine Initiative (IVI), Developing Countries Regulatory Network (DCRN), and BIO Ventures for Global Health (BVGH) will discuss strategies for the development and regulation of preventative vaccines for global diseases. Special emphasis will be given to the WHO prequalification process and FDAAA voucher program relative to global vaccine development for world health. Session topics will include:

 
  • Regulatory Approaches and Pathways for Global Vaccine Development: FDA, EMEA, Emerging Regions and Industry Perspectives
  • Prequalification of Global Vaccines
  • Special Presentation on Ethical Considerations in Global Vaccine Development
  • Novel Approaches to Global Vaccine Development
  • Global Vaccine Development: Path Forward and Open Dialogue
  • Speakers will include:
  • Norman Baylor, PhD, Director, Office of Vaccines Research & Review (OVRR), CBER, FDA
  • David Wood, PhD, Coordinator of the Quality, Safety & Standards Team of the Department of Immunization, Vaccines & Biologicals, WHO
  • Vincent Ahonkhai, MD: Senior Regulatory Officer, Global Health Delivery, Bill and Melinda Gates Foundation
  • Christine Grady, MSN, PhD, Head Section on Human Subjects Research, Department of Bioethics, National Institutes of Health Clinical Center
Jesse Goodman, MD, MPH, Acting Chief Scientist & Deputy Commissioner for Scientific & Medical Programs for FDA, will deliver the keynote address.

"In September 2008 the Center for Biologics Evaluation and Research (CBER) at the US Food and Drug Administration (FDA) published an important FDA Guidance Document that will expand the FDA's role in facilitating the development of new vaccines for global bacterial, viral, and parasitic diseases affecting millions of people in developing countries worldwide," explains Program Co-chair Michael Brennan, PhD, Senior Advisor for Global Affairs, Aeras Global TB Vaccine Foundation. "This symposium will explore this new guidance in depth and discuss the necessary paths to develop vaccines for global diseases."

Click here to register.

About the Drug Information Association (DIA)
DIA serves more than 30,000 professionals involved in the biopharmaceutical industry and regulatory affairs worldwide. Through its domestic and international meetings, training courses, workshops and webinars, DIA provides a neutral global forum for the exchange of information critical to the advancement of the drug discovery and lifecycle management processes. Headquartered in Horsham, PA, USA, and with offices in Basel, Switzerland, Tokyo, Japan, Mumbai, India, and Beijing, China, the Association is led by its volunteer-based Board of Directors and executive management team. For more information, visit www.diahome.org or call 215-442-6100.


Contact: Joe Krasowski
DIA
+1-215-293-5812

###

Read the full story at http://www.prweb.com/releases/2009/09/prweb2963384.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Imagenetix Inc. to Present at Noble Small Cap Financial Conference on August 21, 2007
2. Anesiva to Host Conference Call and Webcast Tomorrow to Discuss Encouraging Development in Zingo(TM) Program
3. Avicena Group to Present at Noble Financial Conference
4. Strategic Diagnostics to Present at Two Upcoming Investor Conferences
5. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
6. CEL-SCI to Present at the Noble Financial Conference
7. NuVasive to Present at Thomas Weisel Partners Healthcare Conference
8. ZymoGenetics Will Hold Conference Call Today at 5:00 p.m. Eastern Time to Provide Update on rThrombin
9. Strategic Diagnostics Updates Roth Conference Presentation Time
10. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2007
11. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
DIA Conference to Provide FDA, EMEA, Health Canada, Emerging Regions, NGO, and Industry Perspectives on Global Vaccine Development
(Date:2/20/2017)... ... February 20, 2017 , ... ... and telemedicine company announces at HIMSS 2017 Annual Conference (Orlando, FL) a ... offered via a global cloud-based sharing and collaboration platform as part of ...
(Date:2/20/2017)... , Feb. 20, 2017  At the ... in Orlando , IBM (NYSE: ... collaborators and clients. IBM Chairman, President and CEO ... opening keynote address today from 8:30-10 am ET, ... , and ibm.com/industries/healthcare. Her remarks examine the advent ...
(Date:2/18/2017)... ... February 17, 2017 , ... The BMT Tandem Meetings of ... International Blood & Marrow Transplant Research (CIBMTR) will take place Feb. 22-26, 2017 ... combined scientific sessions offer investigators, clinicians, laboratory technicians, clinical research professionals, nurses, pharmacists, ...
(Date:2/17/2017)... 2017  BioGenex, a global leader in molecular ... novel system for quantitative immunohistochemistry (IHC). The system ... Rochester (NY, USA) and Konica-Minolta Inc. ( ... able to accurately quantify the expression of an ... factor receptor-2) in clinical samples. Quantitative IHC is ...
Breaking Biology Technology:
(Date:2/2/2017)... 2017   TapImmune, Inc. (NASDAQ: ... in the development of innovative peptide and gene-based ... and metastatic disease, announced today it has successfully ... a second clinical lot of TPIV 200, the ... The manufactured vaccine product will be used to ...
(Date:2/1/2017)... -- IDTechEx Research, a leading provider of independent market ... of a new report, Sensors for Robotics: Technologies, Markets and ... ... ... Report "Sensors for Robotics: Technologies, Markets and Forecasts 2017-2027: Machine vision, ...
(Date:1/26/2017)... 2017  Crossmatch, a leading provider of security and ... at combatting fraud, waste and abuse in assistance operations ... Action on Disaster Relief conference in Panama ... agencies and foreign assistance organizations throughout Latin ... are a largely unacknowledged problem in the foreign assistance ...
Breaking Biology News(10 mins):